Buchumschlag

Review Article: Drug Approval for Gastroparesis—Suggestions for Improving the Process for Positive Results

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Michael Camilleri, Henry P. Parkman
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
von: Michael Camilleri, et al.
Veröffentlicht: (2025)

Review Article: The Evolving Role of GLP ‐1 Receptor Agonists in Gastroenterology Practice
von: Sydney Pomenti, et al.
Veröffentlicht: (2025)

Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
von: Michael Camilleri
Veröffentlicht: (2025)

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation
von: Mohamed H. Eldesouki, et al.
Veröffentlicht: (2026)

Review Article: Drug‐Induced Liver Injury Associated With Antibody‐Based Therapies in Haematologic Malignancies
von: Mengmeng Lin, et al.
Veröffentlicht: (2025)

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
von: Camille Lupianez‐Merly, et al.
Veröffentlicht: (2024)

Letter: Gastroparesis in Lung Transplantation: Time to Reframe and Standardise Post‐Transplant Foregut Motility Evaluation
von: Luisa Bertin, et al.
Veröffentlicht: (2026)

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion
von: Cathy Lu, et al.
Veröffentlicht: (2025)

Letter: Gastroparesis in Lung Transplantation: Time to Reframe and Standardize Post‐Transplant Foregut Motility Evaluation: Authors' Reply
von: Mohamed H. Eldesouki, et al.
Veröffentlicht: (2026)

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice
von: Javier P. Gisbert, et al.
Veröffentlicht: (2026)

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
von: Jörn M. Schattenberg, et al.
Veröffentlicht: (2026)

Editorial for ‘Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance, and Expansion’
von: Cameron Kendall, et al.
Veröffentlicht: (2025)

Review Article: Green Management of IBD—New Paradigms for an Eco‐Friendly Approach
von: Giovanni Cammarota, et al.
Veröffentlicht: (2024)

Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
von: Manjeet Kumar Goyal, et al.
Veröffentlicht: (2026)

Review Article: Individualised Management of Reflux‐Like Symptoms—Strategies Beyond Acid Suppression
von: Peter J. Kahrilas, et al.
Veröffentlicht: (2025)

Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation
von: Erin R. Bonner, et al.
Veröffentlicht: (2025)

Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea
von: Saam Dilmaghani, et al.
Veröffentlicht: (2025)

Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
von: Maryam Zafer, et al.
Veröffentlicht: (2025)

Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study
von: Ronen Stein, et al.
Veröffentlicht: (2025)

Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS‐BAD
von: Camille Lupianez‐Merly, et al.
Veröffentlicht: (2024)

Editorial: Beyond Clinical Trials—Real‐World Data Suggest Usefulness of GLP‐1 RAs in MASLD Treatment. Authors' Reply
von: Chia‐Chih Kuo, et al.
Veröffentlicht: (2025)

Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study
von: Clara Yzet, et al.
Veröffentlicht: (2025)

Editorial: The Role of Liver Biopsy in ANA Positive Subjects
von: Einar S. Björnsson
Veröffentlicht: (2026)

Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia
von: Emily Nash, et al.
Veröffentlicht: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
von: Peter R. Gibson, et al.
Veröffentlicht: (2024)

Editorial: The Role of Liver Biopsy in ANA Positive Subjects. Authors' Reply
von: David Mehdi Asgher Niazi, et al.
Veröffentlicht: (2026)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis?
von: Alessandro Granito, et al.
Veröffentlicht: (2026)

Letter: Drug‐Induced Autoimmune‐Like Hepatitis—A Trigger on the Disease Spectrum. Authors' Reply
von: Pinelopi Arvaniti, et al.
Veröffentlicht: (2025)

Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
von: Konstantinos Papamichael, et al.
Veröffentlicht: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
von: Matthew J. Townsend, et al.
Veröffentlicht: (2024)

Editorial: Prevention of Upper GI Bleeding in Users of Anti‐Thrombotic Drugs—P‐ CABs Versus PPIs
von: Ali S. Taha
Veröffentlicht: (2026)

Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
von: Pinelopi Arvaniti, et al.
Veröffentlicht: (2025)

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis
von: Ao Gao, et al.
Veröffentlicht: (2026)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis? Authors' Reply
von: Hong‐Li Liu, et al.
Veröffentlicht: (2026)

Letter on ‘Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study’
von: Muhammad Ibrahim Khalil, et al.
Veröffentlicht: (2025)

Editorial: Peroxisome Proliferator‐Activated Receptor Agonists—Shifting the Goalpost From Biochemical Response to Symptom Directed Therapy in PBC
von: Henry H. Nguyen, et al.
Veröffentlicht: (2026)

Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium
von: Ann T. Ma, et al.
Veröffentlicht: (2024)

Editorial: Prevention of Upper GI Bleeding in Users of Anti‐Thrombotic Drugs—P‐ CABs Versus PPIs . Authors' Reply
von: Min Joo Yoon, et al.
Veröffentlicht: (2026)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
von: Linda Henry, et al.
Veröffentlicht: (2024)

Diagnostic Impact of Liver Biopsy Among Antinuclear Antibody Positive Individuals With Mild Liver Enzyme Elevation
von: David Mehdi Asgher Niazi, et al.
Veröffentlicht: (2026)